SEC Form 4 · accession 0001209191-15-029176
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopherd T Guiffre
Officer — Chief Executive Officer · Director
Period of report
Mar 23, 2015
Accepted (ET)
Mar 25, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.84 | Mar 23, 2015 | A | 407,520 | A | — | Mar 22, 2025 | Common Stock | 407,520 | 407,520 | D |
Explanation of responses
- F1This option was granted on March 23, 2015. The option vests as to 2.08333% of the underlying shares monthly through and including March 23, 2019.